Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.45 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.39 |
| ▸ | SMYD3 | Q9H7B4 | 11/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6431 | 0.76 | AHR (0.72) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL6523246 | 0.74 | AHR (0.47) | AHRCMA1BRD4TDP2GRIA1 | |
| Formic Acid SCHEMBL29737119 | 0.72 | AHR (0.62) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL29016213 | 0.68 | AHR (0.48) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL4304359 | 0.67 | EPHX2 (0.62) | AHREPHX2SMYD3 | |
| SCHEMBL28607810 | 0.67 | AHR (0.47) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL29016221 | 0.67 | AHR (0.47) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL29016210 | 0.67 | AHR (0.47) | AHRCMA1BRD4EPHX2TDP2 | |
| SCHEMBL3389331 | 0.66 | EPHX2 (0.61) | AHREPHX2SMYD3 | |
| SCHEMBL7715803 | 0.66 | PGR (0.62) | AHRCMA1TDP2GRIA1CACNG8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1427326-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SUGEN INC (US) | 2005-06-08 | — | — | EP | disclosed |
| EP-1427326-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Sugen, Inc. (US) | 2004-06-16 | — | — | EP | disclosed |
| WO-2003015608-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SUGEN, INC. (US) | 2003-02-27 | — | — | WO | disclosed |